β¨ Medicines Distribution Consent
NEW ZEALAND GAZETTE
No. 7
Consent to the Distribution of a Changed Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product:
Xeloda
Active Ingredient:
Capecitabine 150mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer(s):
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Roche Products Limited (trading as Roche Consumer Health), Welwyn Garden City, Hertfordshire, United Kingdom
Note: This product has consent that expires on 5 August 2003.
Product:
Xeloda
Active Ingredient:
Capecitabine 500mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer(s):
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Roche Products Limited (trading as Roche Consumer Health), Welwyn Garden City, Hertfordshire, United Kingdom
Note: This product has consent that expires on 5 August 2003.
Dated this 16th day of January 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go562
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Methotrexate Onco-Vial
Active Ingredient:
Methotrexate 100mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Baxter Healthcare Limited
Manufacturer:
David Bull Laboratories Limited, Mulgrave North, Victoria, Australia
Product:
Methotrexate Onco-Vial
Active Ingredient:
Methotrexate 25mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Baxter Healthcare Limited
Manufacturer:
David Bull Laboratories Limited, Mulgrave North, Victoria, Australia
Product:
Methotrexate
Active Ingredient:
Methotrexate 25mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Baxter Healthcare Limited
Manufacturer:
David Bull Laboratories Limited, Mulgrave North, Victoria, Australia
Product:
Methotrexate
Active Ingredient:
Methotrexate 100mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Baxter Healthcare Limited
Manufacturer:
David Bull Laboratories Limited, Mulgrave North, Victoria, Australia
Product:
Methotrexate
Active Ingredient:
Methotrexate 10mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Baxter Healthcare Limited
Manufacturer:
David Bull Laboratories Limited, Mulgrave North, Victoria, Australia
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2002, No 7
Gazette.govt.nz —
NZ Gazette 2002, No 7
β¨ LLM interpretation of page content
π₯ Consent to Distribution of Changed Medicine
π₯ Health & Social Welfare16 January 2002
Medicine, Distribution Consent, Xeloda, Capecitabine, Roche Products
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to Distribution of Changed Medicines
π₯ Health & Social WelfareMedicines, Distribution Consent, Methotrexate, Baxter Healthcare